|
Delayed
Australian S.E.
20:16:12 2026-09-07 EDT
|
5-day change | 1st Jan Change | ||
| 0.0110 AUD | 0.00% |
|
0.00% | -26.67% |
| 08-26 | Acrux Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 08-24 | Acrux Limited Auditor Raises 'Going Concern' Doubt | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 4.68M | - | - | - | - | - |
| 48.26B | |||||
| 40.5B | |||||
| 11.85B | |||||
| 11.83B | |||||
| 9.36B |
- Stock Market
- Stocks
- ACR Stock
- Charts Acrux Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
